Using such combination strategy in BRAFV600E-positive PTC cells, the expression of iodine-handling genes in thyroid cancer cells increased to a greater extent, localization of NIS to the cell membrane was greater promoted, and radioiodine uptake and toxicity were augmented to a higher level. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.